Clinical Trial Update: A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG [Phase 2]

View source ↗

Summary

Phase 2 trial of divalproex sodium in children with autism spectrum disorder and epileptiform EEG has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• DIVALPROEX SODIUM (divalproex sodium)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Autism, Autism Spectrum Disorders | Phase 2 | Status: WITHDRAWN